🇺🇸 FDA
Patent

US 10918703

Fusion proteins for treating inflammatory diseases

granted A61KA61K38/55A61P

Quick answer

US patent 10918703 (Fusion proteins for treating inflammatory diseases) held by The Regents of the University of California expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/55, A61P, A61P9/10, A61P9/14